Skip to content

Study · Animal study (in vivo) · 1997

2 results

[The delta sleep-inducing peptide, its analogs and the serotoninergic system in the development of anticonvulsant action].

Shandra AA, Godlevskiĭ LS, Brusentsov AI, Petrashevich VP, Vast'ianov RS, Nickel B, Mikhaleva II

Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova1 Aug 1997

PMID9487048 (opens in a new tab)PepBankPUB-09487048

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In animals, delta-sleep-inducing peptide and its analogues protected against seizures.

    In plain wordsIn animals, delta sleep-inducing peptide and its analogues protected against seizures.

    Outcome
    DecreaseSeizure protection
    Study

    n: not reported in source

    Outcome group
    Neuroprotection · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    A seizure-protecting effect of the delta-sleep-inducing peptide (DSIP) and its analogues was revealed.
  2. 02AnimalAnimal study (in vivo)Mechanism

    In animals, delta-sleep-inducing peptide and its analogues increased the sorption of H3 tryptophan.

    In plain wordsIn animals, delta sleep-inducing peptide and its analogues increased uptake of labelled tryptophan.

    Outcome
    IncreaseH3 tryptophan sorption
    Study

    n: not reported in source

    Outcome group
    Receptor activity and mechanism · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    An intensive sorption of H3 tryptophan occurred under the effect of the DSIP and its analogues.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 17:28 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.